Gil Ast

11.2k total citations · 1 hit paper
76 papers, 7.8k citations indexed

About

Gil Ast is a scholar working on Molecular Biology, Plant Science and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gil Ast has authored 76 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 8 papers in Plant Science and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gil Ast's work include RNA Research and Splicing (60 papers), RNA and protein synthesis mechanisms (52 papers) and RNA modifications and cancer (44 papers). Gil Ast is often cited by papers focused on RNA Research and Splicing (60 papers), RNA and protein synthesis mechanisms (52 papers) and RNA modifications and cancer (44 papers). Gil Ast collaborates with scholars based in Israel, United States and Germany. Gil Ast's co-authors include Galit Lev-Maor, Schraga Schwartz, Rotem Sorek, Hadas Keren, Eddo Kim, Amir Goren, Eran Meshorer, Noam Shomron, Oren Ram and Noa Sela and has published in prestigious journals such as Science, Nucleic Acids Research and Nature Communications.

In The Last Decade

Gil Ast

75 papers receiving 7.7k citations

Hit Papers

Alternative splicing and evolution: diversification, exon... 2010 2026 2015 2020 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gil Ast Israel 42 7.0k 1.0k 834 687 290 76 7.8k
Michael D. Wilson Canada 34 4.4k 0.6× 709 0.7× 841 1.0× 915 1.3× 345 1.2× 100 5.5k
Juan M. Vaquerizas Germany 36 5.3k 0.8× 839 0.8× 549 0.7× 944 1.4× 339 1.2× 59 6.2k
Sofie R. Salama United States 24 3.8k 0.5× 972 0.9× 655 0.8× 806 1.2× 241 0.8× 52 4.6k
Chia‐Lin Wei United States 26 4.4k 0.6× 831 0.8× 704 0.8× 766 1.1× 217 0.7× 55 5.1k
Hiram Clawson United States 17 4.6k 0.7× 894 0.9× 1.1k 1.3× 1.7k 2.4× 259 0.9× 23 5.7k
Devon Ryan Germany 12 4.2k 0.6× 933 0.9× 481 0.6× 569 0.8× 452 1.6× 19 5.1k
Gunnar Schotta Germany 39 5.6k 0.8× 1.1k 1.1× 400 0.5× 829 1.2× 292 1.0× 77 6.3k
Jürg Müller Germany 40 6.3k 0.9× 1.1k 1.0× 297 0.4× 936 1.4× 322 1.1× 75 7.2k
Elliott H. Margulies United States 32 3.8k 0.5× 686 0.7× 563 0.7× 1.5k 2.1× 293 1.0× 51 5.1k
Dimos Gaidatzis Switzerland 35 6.1k 0.9× 1.1k 1.1× 1.8k 2.2× 799 1.2× 374 1.3× 44 6.8k

Countries citing papers authored by Gil Ast

Since Specialization
Citations

This map shows the geographic impact of Gil Ast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Ast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Ast more than expected).

Fields of papers citing papers by Gil Ast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gil Ast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Ast. The network helps show where Gil Ast may publish in the future.

Co-authorship network of co-authors of Gil Ast

This figure shows the co-authorship network connecting the top 25 collaborators of Gil Ast. A scholar is included among the top collaborators of Gil Ast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gil Ast. Gil Ast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lev-Maor, Galit, et al.. (2023). Human histone H1 variants impact splicing outcome by controlling RNA polymerase II elongation. Molecular Cell. 83(21). 3801–3817.e8. 8 indexed citations
2.
Keydar, Ifat, et al.. (2021). The upstream 5′ splice site remains associated to the transcription machinery during intron synthesis. Nature Communications. 12(1). 4545–4545. 18 indexed citations
3.
Brownstein, Zippora, Süleyman Gülsüner, Morad Khayat, et al.. (2018). Genetics of hearing loss in the Arab population of Northern Israel. European Journal of Human Genetics. 26(12). 1840–1847. 19 indexed citations
4.
Ast, Gil, et al.. (2015). The alternative role of DNA methylation in splicing regulation. Trends in Genetics. 31(5). 274–280. 388 indexed citations
5.
Keren‐Shaul, Hadas, Galit Lev-Maor, & Gil Ast. (2013). Pre-mRNA Splicing Is a Determinant of Nucleosome Organization. PLoS ONE. 8(1). e53506–e53506. 22 indexed citations
6.
Schwartz, Schraga, Oren Ram, & Gil Ast. (2011). Detection and Removal of Biases in the Analysis of Next-Generation Sequencing Reads. PLoS ONE. 6(1). e16685–e16685. 69 indexed citations
7.
Sela, Noa, Britta Mersch, Agnes Hotz‐Wagenblatt, & Gil Ast. (2010). Characteristics of Transposable Element Exonization within Human and Mouse. PLoS ONE. 5(6). e10907–e10907. 61 indexed citations
8.
Schwartz, Schraga, Eran Meshorer, & Gil Ast. (2009). Chromatin organization marks exon-intron structure. Nature Structural & Molecular Biology. 16(9). 990–995. 467 indexed citations
9.
Levy, Asaf, Schraga Schwartz, & Gil Ast. (2009). Large-scale discovery of insertion hotspots and preferential integration sites of human transposed elements. Nucleic Acids Research. 38(5). 1515–1530. 26 indexed citations
10.
Lev-Maor, Galit, Oren Ram, Eddo Kim, et al.. (2008). Intronic Alus Influence Alternative Splicing. PLoS Genetics. 4(9). e1000204–e1000204. 119 indexed citations
11.
Kim, Eddo, Amir Goren, & Gil Ast. (2008). Alternative splicing and disease. RNA Biology. 5(1). 17–19. 33 indexed citations
12.
Goren, Amir, Eddo Kim, Maayan Amit, et al.. (2007). Alternative approach to a heavy weight problem. Genome Research. 18(2). 214–220. 11 indexed citations
13.
Amit, Maayan, Amanda O’Donnell, Chen Farhy, et al.. (2007). Regulation of transcription of the RNA splicing factor hSlu7 by Elk-1 and Sp1 affects alternative splicing. RNA. 13(11). 1988–1999. 13 indexed citations
14.
Ast, Gil. (2004). How did alternative splicing evolve?. Nature Reviews Genetics. 5(10). 773–782. 419 indexed citations
15.
Vig, Ida, et al.. (2004). Comparative analysis detects dependencies among the 5′ splice-site positions. RNA. 10(5). 828–840. 165 indexed citations
16.
Sorek, Rotem, Galit Lev-Maor, Tal Dagan, et al.. (2004). Minimal Conditions for Exonization of Intronic Sequences. Molecular Cell. 14(2). 221–231. 136 indexed citations
17.
Shomron, Noam, et al.. (2004). Splicing Factor hSlu7 Contains a Unique Functional Domain Required to Retain the Protein within the Nucleus. Molecular Biology of the Cell. 15(8). 3782–3795. 11 indexed citations
18.
Lev-Maor, Galit, Rotem Sorek, Noam Shomron, & Gil Ast. (2003). The Birth of an Alternatively Spliced Exon: 3' Splice-Site Selection in Alu Exons. Science. 300(5623). 1288–1291. 346 indexed citations
19.
Shomron, Noam, et al.. (2003). The U1 snRNP Base Pairs with the 5′ Splice Site within a Penta-snRNP Complex. Molecular and Cellular Biology. 23(10). 3442–3455. 41 indexed citations
20.
Richler, Carmelit, Gil Ast, Ruth Goitein, et al.. (1994). Splicing components are excluded from the transcriptionally inactive XY body in male meiotic nuclei.. Molecular Biology of the Cell. 5(12). 1341–1352. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026